ALXO - ALX Oncology GAAP EPS of -$0.81 misses by $0.18 August, 08 2022 05:39 PM ALX Oncology Holdings Inc. ALX Oncology press release ( NASDAQ: ALXO ): Q2 GAAP EPS of -$0.81 misses by $0.18 . Cash, cash equivalents and investments as of June 30, 2022 were $324.2 million. For further details see: ALX Oncology GAAP EPS of -$0.81 misses by $0.18